RESUMEN
Introduction: This study aims to (1) determine the average and most demanding passage (MDP) load of national-level female soccer matches and (2) evaluate the relationship between average and MDP load during small-sided games (SSGs), large-sided games (LSGs), and matches. Methods: A total of 37 national-level female soccer players from a single club senior team and the U18 team participated. The average and 1-, 3-, and 5-min MDP external (total, high-speed, and very-high-speed running distances, acceleration and deceleration distances, average metabolic power, and high-metabolic load distance) and internal loads (average heart rate, rate of perceived exertion) of the 29 league matches, ten 4 vs. 4 + goalkeepers SSGs, and six 8 vs. 8 + goalkeepers LSGs were analyzed by the Polar Team Pro player tracking system. Results: In matches, the external load variables during 1-, 3-, and 5-min MDPs were 167%-1,165%, 135%-504%, and 126%-359%, of match average values, respectively. In LSGs, all external load variables reached higher average values compared with those during matches, except for the very-high-speed running distance; however, no variable reached higher values of 1-min MDP compared with those during the matches. In SSGs, the average acceleration and deceleration distances were higher compared with those during the matches. Discussion: The findings from the present study suggest that LSGs and SSGs can be used to overload the average values of the selected external load variables compared with those during the matches; however, other training options must be explored to overload 1-min match MDPs.
RESUMEN
OBJECTIVES: The objective of this study was to identify the proportion of abdominal aortic aneurysm ruptures that occur before the screening age or threshold diameter for operative repair is reached. METHODS: The study was a retrospective analysis of RAAA patients including all RAAA patients admitted to Helsinki (HUH) and Tampere University Hospitals (TaUH) during 2002-2013. The data for age, gender, and comorbidities were collected from vascular registry and patient records. Computed tomography images taken at the time of admission were used for the measurement of maximum anteroposterior (AP) aneurysm diameter at the time of rupture. Age and diameter data were compared with risk factors. RESULTS: A total of 585 patients diagnosed with RAAA were admitted to the two hospitals during the 12 year period. The mean age at the time of rupture was 73.6 years (SD 9.5, range 42-96 years). 18.3% of patients were under 65: 21.4% of men and 3.0% of women. Men were on average 8 years younger than women. The odds ratio (OR) for rupture before 65 years of age for smokers was 2.1 compared with non-smokers, and 28.4% of smokers were under 65 at the time of rupture. Of all RAAA patients, 327 had a computed tomography scan confirming rupture. The mean AP diameter of the aneurysm was 75.6 mm (SD 15.8, range 32-155 mm). The mean size was significantly lower in women than in men (70.5 vs. 76.8, p = .005). CONCLUSIONS: The data from this study show that a fifth of men would not make it to the screening age of 65 before AAA rupture, the proportion being even larger in active smokers. The data from this study also supports the previous finding that aneurysm size at the time of rupture is significantly smaller in women.
Asunto(s)
Aneurisma de la Aorta Abdominal/epidemiología , Rotura de la Aorta/epidemiología , Tamizaje Masivo , Adulto , Factores de Edad , Anciano , Anciano de 80 o más Años , Aneurisma de la Aorta Abdominal/diagnóstico por imagen , Aneurisma de la Aorta Abdominal/cirugía , Rotura de la Aorta/diagnóstico por imagen , Rotura de la Aorta/cirugía , Aortografía/métodos , Procedimientos Quirúrgicos Electivos , Femenino , Finlandia/epidemiología , Humanos , Modelos Logísticos , Masculino , Tamizaje Masivo/métodos , Persona de Mediana Edad , Análisis Multivariante , Oportunidad Relativa , Valor Predictivo de las Pruebas , Estudios Retrospectivos , Factores de Riesgo , Factores Sexuales , Fumar/efectos adversos , Fumar/epidemiología , Tomografía Computarizada por Rayos X , Procedimientos Quirúrgicos VascularesRESUMEN
AIMS: Nephropathia epidemica (NE) is mild type of hemorrhagic fever caused by Puumala (PUU) hantavirus. Renal biopsy typically shows acute tubulointerstitial nephritis and complete recovery is the usual outcome. We previously described 5 patients with membranoproliferative glomerulonephritis (MPGN) after acute NE. We now report on 7 more patients who developed biopsy-confirmed glomerulonephritis (GN) during the convalescent phase of NE. MATERIAL AND METHODS: We present case histories of 7 patients with nephrotic-range proteinuria concomitant with hematuria after serologically verified NE. RESULTS: Renal biopsy specimens disclosed MPGN in 5 patients, membranous GN (MGN) in 1 and mesangial GN (MesGN) in 1. All patients achieved remission of nephrotic syndrome within a median time of 0.6 years (range 0.5 - 5.5 y). The median follow-up time was 1.7 years (0.7 - 15.6 y). CONCLUSIONS: As a rare phenomenon, nephrotic syndrome may emerge during the convalescent phase of acute PUU hantavirus infection. In most cases the prognosis of GN caused by NE seems to be favorable.
Asunto(s)
Glomerulonefritis Membranoproliferativa/virología , Fiebre Hemorrágica con Síndrome Renal/complicaciones , Virus Puumala , Adulto , Biopsia , Femenino , Finlandia , Glomerulonefritis Membranoproliferativa/diagnóstico , Glomerulonefritis Membranoproliferativa/tratamiento farmacológico , Humanos , Masculino , Persona de Mediana EdadRESUMEN
This study of perceptual and motor skills in soccer players was conducted on adolescent males. The goals were to monitor the development of general perceptual motor skills in nonsoccer-playing and soccer-playing groups (n = 245), to examine the relationship between physical maturity and general perceptual motor skills (n = 41), and to compare the differences in general perceptual motor skills between groups with different soccer expertise (n = 142). The measured variables were simple reaction time, peripheral awareness, eye-hand-foot coordination, and testosterone blood level. The results suggested that general perceptual motor skills improved with age, the development of these skills was related to participants' blood testosterone concentration (especially between 12 and 14 years), and general perceptual motor skills improved with soccer expertise. However, the differences between subelite and elite soccer players were not meaningful enough to encourage practitioners to test general perceptual motor skills on a large scale when evaluating the potential of young players.
Asunto(s)
Rendimiento Atlético , Práctica Psicológica , Psicología del Adolescente , Desempeño Psicomotor , Fútbol/psicología , Adolescente , Factores de Edad , Concienciación/fisiología , Niño , Humanos , Masculino , Orientación/fisiología , Desempeño Psicomotor/fisiología , Tiempo de Reacción/fisiología , Fútbol/fisiología , Testosterona/sangre , Campos Visuales/fisiologíaRESUMEN
Activins and inhibins are structurally related glycoprotein hormones modulating pituitary FSH secretion and gonadal steroidogenesis. Activins and inhibins are also produced in the adrenal cortex where their physiological role is poorly known. Hormonally active human adrenocortical tumors express and secrete inhibins, while in mice adrenal inhibins may function as tumor suppressors. To clarify the significance of adrenal activins and inhibins we investigated the localization of activin/inhibin signaling components in the adrenal gland, and the effects of activins and inhibins on adrenocortical steroidogenesis and apoptosis. Activin receptor type II/IIB and IB, activin signal transduction proteins Smad2/3, and inhibin receptor betaglycan were expressed throughout the adrenal cortex, whereas Smad4 expression was seen mainly in the zona reticularis and the innermost zona fasciculata as evaluated by immunohistochemistry. Treatment of cultured adrenocortical carcinoma NCI-H295R cells with activin A inhibited steroidogenic acute regulatory protein and 17alpha-hydroxylase/17,20-lyase mRNA accumulation as evaluated by the Northern blot technique, and decreased cortisol, androstenedione, dehydroepiandrosterone and dehydroepiandrosterone sulfate secretion as determined by specific enzyme immunoassays. Activin A increased apoptosis as measured by a terminal deoxynucleotidyl transferase in situ apoptosis detection method. Inhibins had no effect on steroidogenesis or apoptosis. In summary, activin/inhibin signaling components are coexpressed in the zona reticularis and the innermost zona fasciculata indicating full signaling potential for adrenal activins and inhibins in these layers. Activin inhibits steroidogenic enzyme gene expression and steroid secretion, and increases apoptosis in human adrenocortical cells. Thus, the activin-inhibin system may have a significant role in the regulation of glucocorticoid and androgen production and apoptotic cell death in the human adrenal cortex.
Asunto(s)
Activinas/análisis , Glándulas Suprarrenales/metabolismo , Hormona Adrenocorticotrópica/biosíntesis , Inhibinas/análisis , Proteínas , Transducción de Señal/fisiología , Receptores de Activinas Tipo I/análisis , Receptores de Activinas Tipo II/análisis , Activinas/genética , Activinas/farmacología , Corticoesteroides/biosíntesis , Glándulas Suprarrenales/química , Glándulas Suprarrenales/citología , Adulto , Apoptosis , Northern Blotting/métodos , Línea Celular Tumoral , Fragmentación del ADN , Proteínas de Unión al ADN/análisis , Proteínas de Unión al ADN/genética , Humanos , Inhibinas/genética , Inhibinas/farmacología , Proteoglicanos/análisis , Proteoglicanos/genética , ARN Mensajero/análisis , Receptores de Factores de Crecimiento Transformadores beta/análisis , Receptores de Factores de Crecimiento Transformadores beta/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Proteína Smad2 , Estadísticas no Paramétricas , Transactivadores/análisis , Transactivadores/genética , Zona Fascicular/química , Zona Fascicular/metabolismo , Zona Reticular/química , Zona Reticular/metabolismoRESUMEN
Activin and its binding protein follistatin may act as local regulators of cell growth and steroidogenesis in the human ovary. The recently identified follistatin-related gene (FLRG) is expressed abundantly in the human ovary, has high affinity for activin, and is able to inhibit activin-induced transcriptional responses. However, little is known about the regulation of FLRG expression in specific cell types in the ovary, while it is known that gonadotrophins induce follistatin gene expression in human granulosa-luteal cells. In this study, we investigated the expression of FLRG mRNA in granulosa-luteal cells of preovulatory follicles obtained from women undergoing IVF. FLRG mRNA was detected by RT-PCR in fresh and cultured granulosa-luteal cells, as well as in normal ovarian stroma, theca and granulosa cells. Northern blot analysis revealed a 2.5 kb transcript of the FLRG in cultured granulosa-luteal cells. The protein kinase C activator, 12-O-tetradecanoyl phorbol 13-acetate (TPA, 160 nmol/l), and prostaglandin E(2) (PGE(2), 1 micromol/l) increased FLRG mRNA accumulation up to 3-8 fold over the control level after 24 h of treatment, and these stimulatory effects were dose-dependent. Co-treatment with the protein kinase C inhibitor, Ro-31-8220 (3 micromol/l), blocked the stimulatory effect of TPA. Although short term treatment with the protein kinase A activator, (Bu)(2)cAMP (1 mmol/l), slightly reduced FLRG mRNA expression in most experiments, long term treatment with FSH (100 IU/l), LH (100 IU/l), or (Bu)(2)cAMP had no significant effect on the FLRG mRNA levels. As expected, gonadotrophins, protein kinase A and C activators and PGE(2) increased granulosa-luteal cell progesterone secretion into the culture media. Taken together, previous and our present data suggest that protein kinase C and A signal transduction pathways differently regulate the expression of FLRG and follistatin genes in human ovarian granulosa-luteal cells.
Asunto(s)
Dinoprostona/metabolismo , Proteínas Relacionadas con la Folistatina/genética , Regulación de la Expresión Génica , Células Lúteas/fisiología , Proteína Quinasa C/metabolismo , Bucladesina/farmacología , Células Cultivadas , Dinoprostona/farmacología , Relación Dosis-Respuesta a Droga , Activación Enzimática/efectos de los fármacos , Inhibidores Enzimáticos/farmacología , Femenino , Hormona Folículo Estimulante/farmacología , Proteínas Relacionadas con la Folistatina/efectos de los fármacos , Proteínas Relacionadas con la Folistatina/metabolismo , Humanos , Indoles/farmacología , Células Lúteas/citología , Células Lúteas/efectos de los fármacos , Hormona Luteinizante/farmacología , Ovario/fisiología , Progesterona/metabolismo , Proteína Quinasa C/antagonistas & inhibidores , ARN Mensajero/metabolismo , Proteínas Recombinantes/farmacología , Transducción de Señal , Acetato de Tetradecanoilforbol/farmacologíaRESUMEN
Pituitary gonadotropins mediate part of their effects on ovarian function via local hormones and growth factors produced by granulosa cells. Activins and inhibins are among these factors, and they have often opposite effects on various components of the reproductive system. The purpose of this study was to investigate the regulation of ovarian activin A secretion using cultured human ovarian granulosa-luteal cells as a model. The granulosa-luteal cells, obtained from women taking part in an in vitro fertilization program, were cultured and treated with FSH, LH, 8-bromo cAMP (8-BrcAMP, a protein kinase A activator) and 12-O-tetradecanoyl phorbol-13-acetate (TPA, a protein kinase C activator). Conditioned cell culture media were analyzed for activin A, inhibin A and progesterone concentrations with specific enzyme immunoassays. FSH and LH (1-100 IU/l) increased activin A secretion with 24 h of treatment (to 132% and 253% of control respectively; P<0.05 for both), but their effects were inhibitory in 48-h treatments (26% and 16% decreases respectively; P<0.05 for both). In the same experiments, FSH and LH increased inhibin A and progesterone secretion after both 24 and 48 h of treatment. 8-BrcAMP (0.1-100 muM) increased activin A in 24- and 48-h experiments (to 206% and 148% of control respectively; P<0.01 for both). Inhibin A and progesterone secretion were stimulated by 8-BrcAMP time- and dose-dependently. TPA increased activin A secretion dose-dependently (0.1-100 ng/ml) in both 24- and 48-h experiments. At 100 ng/ml concentration, it increased activin A up to 61-fold and inhibin A up to 16-fold of control in 24-h experiments. We conclude that gonadotropins regulate immunoreactive activin A secretion biphasically in cultured human granulosa-luteal cells: initial stimulation is followed by inhibition. In contrast, gonadotropins increase inhibin A and progesterone secretion continuously. Consequently, continuing gonadotropin stimulation leads to a decreasing activin:inhibin ratio, which may have a significant role in the local fine-tuning of ovarian steroidogenesis.
Asunto(s)
Activinas/metabolismo , Gonadotropinas Hipofisarias/farmacología , Células de la Granulosa/metabolismo , Subunidades beta de Inhibinas/metabolismo , Inhibinas/metabolismo , 8-Bromo Monofosfato de Adenosina Cíclica/farmacología , Células Cultivadas , Proteínas Quinasas Dependientes de AMP Cíclico/metabolismo , Relación Dosis-Respuesta a Droga , Activación Enzimática , Femenino , Hormona Folículo Estimulante/farmacología , Células de la Granulosa/efectos de los fármacos , Humanos , Hormona Luteinizante/farmacología , Progesterona/metabolismo , Proteína Quinasa C/metabolismo , Tasa de Secreción/efectos de los fármacos , Estadísticas no Paramétricas , Estimulación Química , Acetato de Tetradecanoilforbol/farmacología , Factores de TiempoRESUMEN
Inhibins are gonadal glycoproteins with endocrine effects on pituitary FSH secretion and para/autocrine effects on ovarian and testicular function. The purpose of this study was to investigate the endocrine and para/autocrine regulation of inhibin A and inhibin B secretion in human ovarian granulosa-luteal cells. The cells were obtained from women undergoing in vitro fertilization, and the primary cultures were treated with FSH, LH, human chorionic gonadotropin (hCG), activin A, 8-bromo cyclic AMP (8-BrcAMP), staurosporine (a protein kinase C inhibitor) and an antagonist of IGF action (type-1 IGF receptor antibody alpha IR3). The secretion of inhibins was measured by ELISA assays capable of reliably distinguishing between inhibin A and B. FSH, LH, hCG and 8-BrcAMP increased inhibin A secretion on average up to 180% (P<0.01), 192% (P<0.05), 210% (P<0.01) and 243% (P<0.01) respectively of the control level, while their stimulatory effect on inhibin B secretion was less pronounced (up to 167%, P<0.01; 139%, P<0.05; 127%, P>0.05; 133%, P>0.05 of the controls respectively). alpha IR3 decreased inhibin A and B secretion down to 70% (P<0.01) and 50% (P<0.01) respectively of the control. Staurosporine decreased inhibin B secretion down to 49% (P<0.01) of the control; its effect on inhibin A secretion was not significant. Activin A increased inhibin B secretion up to fourfold of the control (P<0.05) while its effect on inhibin A secretion was insignificant. We conclude that gonadotropins via the protein kinase A signal transduction pathway are the main positive regulators of inhibin A and B secretion in human granulosa-luteal cells. The protein kinase C signal transduction pathway seems to be important especially for inhibin B secretion. Locally produced IGFs are probably important inducers of the production of both forms of inhibin in human ovaries while activins seem to upregulate inhibin B secretion.
Asunto(s)
Cuerpo Lúteo/metabolismo , Gonadotropinas/farmacología , Células de la Granulosa/metabolismo , Inhibinas/metabolismo , Activinas , Técnicas de Cultivo de Célula , Gonadotropina Coriónica/farmacología , Cuerpo Lúteo/citología , Proteínas Quinasas Dependientes de AMP Cíclico/fisiología , Femenino , Hormona Folículo Estimulante/farmacología , Humanos , Inhibinas/farmacología , Hormona Luteinizante/farmacología , Proteína Quinasa C/fisiología , Receptor IGF Tipo 1/metabolismo , Proteínas Recombinantes/farmacología , Transducción de Señal/fisiologíaAsunto(s)
Partería/tendencias , Enfermeras Obstetrices/normas , Competencia Profesional , Adulto , Competencia Clínica , Escolaridad , Femenino , Finlandia , Humanos , Recién Nacido , Masculino , EmbarazoAsunto(s)
Paraproteinemias/complicaciones , Xantomatosis/complicaciones , Antiinflamatorios/uso terapéutico , Humanos , Hiperlipidemias/complicaciones , Lipoproteínas/metabolismo , Masculino , Persona de Mediana Edad , Paraproteínas/metabolismo , Prednisolona/uso terapéutico , Vasculitis/complicaciones , Xantomatosis/diagnóstico , Xantomatosis/tratamiento farmacológicoAsunto(s)
Derivaciones del Líquido Cefalorraquídeo/efectos adversos , Glomerulonefritis Membranoproliferativa/etiología , Infecciones Estafilocócicas/complicaciones , Adulto , Femenino , Glomerulonefritis Membranoproliferativa/patología , Humanos , Microscopía Electrónica , Infecciones Estafilocócicas/microbiología , Staphylococcus epidermidis/aislamiento & purificaciónRESUMEN
Eighteen patients with chronic renal failure (serum creatinine 173-756 mumol/l) and hyperlipidemia were treated with gemfibrozil (1200 mg/day). The drug caused a significant improvement of the dyslipidemia within one week and the effect was progressive during the 28 weeks of treatment. Very-low-density lipoprotein triglycerides and very-low-density lipoprotein cholesterol decreased by about 50% and high-density lipoprotein cholesterol increased by 30%. The lipoprotein changes occurred simultaneously with a significant activation to normal levels of postheparin plasma lipoprotein and hepatic lipases. Opposite effects were observed when gemfibrozil was discontinued and the patients were given placebo. No major harmful effects were observed.
Asunto(s)
Fallo Renal Crónico/sangre , Lipasa/deficiencia , Lipoproteína Lipasa/deficiencia , Hígado/enzimología , Ácidos Pentanoicos/uso terapéutico , Valeratos/uso terapéutico , Adulto , Anciano , Ensayos Clínicos como Asunto , Activación Enzimática/efectos de los fármacos , Femenino , Gemfibrozilo , Humanos , Fallo Renal Crónico/tratamiento farmacológico , Lipoproteínas/sangre , Masculino , Persona de Mediana Edad , Triglicéridos/sangreRESUMEN
A 34 year old woman is described in whom carditis, arthritis, fever, leukocytosis and a high sedimentation rate developed two weeks after a streptococcal infection. The patient also had the nephrotic syndrome and rapidly progressive renal insufficiency. The renal biopsy specimen showed acute extracapillary (crescentic) glomerulonephritis. The initial response to corticosteroid therapy was good, but later a slowly progressive renal function impairment was seen.
Asunto(s)
Glomerulonefritis/etiología , Síndrome Nefrótico/etiología , Fiebre Reumática/etiología , Infecciones Estreptocócicas/complicaciones , Tonsilitis/complicaciones , Enfermedad Aguda , Adulto , Sedimentación Sanguínea , Femenino , Humanos , Leucocitosis/etiologíaRESUMEN
The furosemide-induced increase in protein excretion, and its relations to 1) the size of protein molecules as reflected by three enzymes, and 2) glomerular filtration rate (GFR), plasma renin activity (PRA) and prostaglandin (PG) E2 and F2 alpha excretions were studied in 14 outpatients with normal renal function and 13 healthy males. Furosemide (120 mg) was given intravenously, and thereafter the protein excretion and the above parameters were monitored for 1--2 hours. In both groups, furosemide caused a transient increase in protein excretion. The excretion of the largest molecule, beta-glucuronidase, rose to 6.3-fold, while those of N-acetyl-beta-D-glucosaminidase and of the smallest molecule, alpha-amylase, increased by 91 and 37%, respectively. GFR increased, too, but markedly less than the protein excretion. PGE2 and PGF2 alpha excretions increased more than GFR and changed simultaneously with the excretion of proteins. Furosemide also caused a marked increase in PRA. This lasted, however, much longer than the rise in PG and protein excretion or GFR. The results suggest that the furosemide-induced increase in protein excretion is 1) related to the molecular size of proteins, 2) partly due to the rise in GFR, 3) simultaneous with the change in PG excretion. Our findings also agree with the view that furosemide causes changes in glomerular permeability.
Asunto(s)
Furosemida/farmacología , Proteinuria/inducido químicamente , Acetilglucosaminidasa/metabolismo , Adulto , Femenino , Furosemida/administración & dosificación , Tasa de Filtración Glomerular , Glucuronidasa/metabolismo , Humanos , Inyecciones Intravenosas , Masculino , Persona de Mediana Edad , Prostaglandinas E/metabolismo , Prostaglandinas F/metabolismo , Renina/sangre , alfa-Amilasas/metabolismoRESUMEN
A 26-year-old man developed pneumonia, hepatitis and biopsy-verified acute tubulointerstitial nephritis coinciding with a rise and fall of complement-fixing antibodies to Mycoplasma pneumoniae. M. pneumoniae antigenic material and complement (C3) in the renal interstitium were shown by immunohistochemical techniques. A causal relationship between M. pneumoniae infection and the renal lesion is suggested.